These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37759310)

  • 21. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
    Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
    Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of the cancer stem cell niche and therapeutic strategies.
    Ju F; Atyah MM; Horstmann N; Gul S; Vago R; Bruns CJ; Zhao Y; Dong QZ; Ren N
    Stem Cell Res Ther; 2022 Jun; 13(1):233. PubMed ID: 35659296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Stem Cell Niche in Colorectal Cancer and Targeted Therapies.
    Wang H; Cui G; Yu B; Sun M; Yang H
    Curr Pharm Des; 2020; 26(17):1979-1993. PubMed ID: 32268862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes.
    Marengo A; Forciniti S; Dando I; Dalla Pozza E; Stella B; Tsapis N; Yagoubi N; Fanelli G; Fattal E; Heeschen C; Palmieri M; Arpicco S
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):61-72. PubMed ID: 30267751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells.
    Vaz AP; Ponnusamy MP; Rachagani S; Dey P; Ganti AK; Batra SK
    Br J Cancer; 2014 Jul; 111(3):486-96. PubMed ID: 25003666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCSCdb: a database of biomarkers of cancer stem cells.
    Firdous S; Ghosh A; Saha S
    Database (Oxford); 2022 Sep; 2022():. PubMed ID: 36169329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of protumoral CD11c(high) macrophages by glioma cancer stem cells through GM-CSF.
    Kokubu Y; Tabu K; Muramatsu N; Wang W; Murota Y; Nobuhisa I; Jinushi M; Taga T
    Genes Cells; 2016 Mar; 21(3):241-51. PubMed ID: 26805963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation.
    Polireddy K; Dong R; McDonald PR; Wang T; Luke B; Chen P; Broward M; Roy A; Chen Q
    PLoS One; 2016; 11(10):e0164811. PubMed ID: 27764163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NiCHE Platform: Nature-Inspired Catechol-Conjugated Hyaluronic Acid Environment Platform for Salivary Gland Tissue Engineering.
    Lee SW; Ryu JH; Do MJ; Namkoong E; Lee H; Park K
    ACS Appl Mater Interfaces; 2020 Jan; 12(4):4285-4294. PubMed ID: 31903749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The secretome of colon cancer stem cells contains drug-metabolizing enzymes.
    Emmink BL; Verheem A; Van Houdt WJ; Steller EJ; Govaert KM; Pham TV; Piersma SR; Borel Rinkes IH; Jimenez CR; Kranenburg O
    J Proteomics; 2013 Oct; 91():84-96. PubMed ID: 23835434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer stem cells and their niche in cancer progression and therapy.
    Liu Q; Guo Z; Li G; Zhang Y; Liu X; Li B; Wang J; Li X
    Cancer Cell Int; 2023 Dec; 23(1):305. PubMed ID: 38041196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cells in breast tumours: are they ready for the clinic?
    Ablett MP; Singh JK; Clarke RB
    Eur J Cancer; 2012 Sep; 48(14):2104-16. PubMed ID: 22542086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Polymeromics": Mass spectrometry based strategies in polymer science toward complete sequencing approaches: a review.
    Altuntaş E; Schubert US
    Anal Chim Acta; 2014 Jan; 808():56-69. PubMed ID: 24370093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-146b-3p regulates proliferation of pancreatic cancer cells with stem cell-like properties by targeting MAP3K10.
    Zhou M; Gao Y; Wang M; Guo X; Li X; Zhu F; Xu S; Qin R
    J Cancer; 2021; 12(12):3726-3740. PubMed ID: 33995647
    [No Abstract]   [Full Text] [Related]  

  • 38. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scaffold-based 3D cellular models mimicking the heterogeneity of osteosarcoma stem cell niche.
    Bassi G; Panseri S; Dozio SM; Sandri M; Campodoni E; Dapporto M; Sprio S; Tampieri A; Montesi M
    Sci Rep; 2020 Dec; 10(1):22294. PubMed ID: 33339857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.